During the past decade, Forschungszentrum Ruhr conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forschungszentrum Ruhr" #1 sponsor was "Amgen" with 3 trials, followed by "Bayer" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Novartis" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forschungszentrum Ruhr" #1 collaborator was "University of Perugia, Italy" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Forschungszentrum Ruhr" are "Alzheimer Disease" (2 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Forschungszentrum Ruhr" in a lesser frequency.

Most popular intervention types in "Forschungszentrum Ruhr" are "Drug" (14 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apixaban" (2 trials), "Evolocumab" (2 trials), "Gantenerumab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Forschungszentrum Ruhr" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Forschungszentrum Ruhr". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Forschungszentrum Ruhr, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Forschungszentrum Ruhr, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".